Peptidomimetic-functionalized carbon nanotubes with antitrypsin activity

Carbon

Volumn 47, Issue 15, 2009, Pages 3550-3558

  Karousis, Nikolaos ^a   Papi, Rigini M ^b   Siskos, Argiris ^b   Vakalopoulou, Paraskevi ^c   Glezakos, Petros ^c   Sarigiannis, Yiannis ^c   Stavropoulos, Georgios ^c   Kyriakidis, Dimitrios A ^a,b   Tagmatarchis, Nikos ^a  

^a THEORETICAL AND PHYSICAL CHEMISTRY INSTITUTE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPSIN; BIOLOGICAL APPLICATIONS; BIOLOGICAL EVALUATION; DRUG DELIVERY SYSTEM; FUNCTIONALIZED; FUNCTIONALIZED CARBON NANOTUBES; INHIBITORY EFFECT; MORPHOLOGICAL CHARACTERIZATION; NANO-SIZED; PEPTIDOMIMETICS; SPECTROSCOPIC METHOD; STRUCTURAL SIMILARITY; THERMAL ANALYSIS; TRYPSIN INHIBITORY ACTIVITY;

DRUG DELIVERY; RECONSTRUCTION (STRUCTURAL); SPECTROSCOPIC ANALYSIS; STRUCTURAL DESIGN; THERMOANALYSIS;

CARBON NANOTUBES;

EID: 70349141736     PISSN: 00086223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbon.2009.08.025     Document Type: Article

References (66)

1. Klumpp C., Kostarelos K., Prato M., and Bianco A. Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochim Biophys Acta 1758 (2006) 404-412
2. Bianco A., Kostarelos K., Partidos C., and Prato M. Biomedical applications of functionalized carbon nanotubes. Chem Commun (2005) 571-577
3. Bianco A., Kostarelos K., and Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9 (2005) 674-679
4. Tasis D., Tagmatarchis N., Georgakilas V., and Prato M. Soluble carbon nanotubes. Chem Eur J 9 (2003) 4000-4008
5. Wong S., Joselevich E., Woolley A., Cheung C., and Lieber C. Covalently functionalized nanotubes as nanometresized probes in chemistry and biology. Nature 394 (1998) 52-55
6. Dyke B., and Tour J. Overcoming the insolubility of carbon nanotubes through high degrees of sidewall functionalization. Chem Eur J 10 (2004) 812-817
7. Singh R., Pantarotto D., McCarthy D., Chaloin O., Hoebeke J., Partidos C., et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc 127 (2005) 4388-4396
8. Lovat V., Pantarotto D., Lagostena L., Spalluto G., Prato M., Ballerini L., et al. Carbon nanotube substrates boost neuronal electrical signaling. Nano Lett 5 (2005) 1107-1110
9. Hu H., Haddon R., Ni Y., Montana V., and Parpura V. Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett 4 (2004) 507-511
10. Mattson M., Haddon R., and Rao A. Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J Mol Neurosci 14 (2000) 175-182
11. Galvan-Garcia P., Keefer E.W., Yang F., Zhang M., Fang S., Zakhidov A.A., et al. Robust cell migration and neuronal growth on pristine carbon nanotube sheets and yarns. J Biomater Sci, Polym Ed 18 (2007) 1245-1261
12. Foldvari M., and Bagonluri M. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine 4 (2008) 183-200
13. Usui Y., Aoki K., Narita N., Murakami N., Nakamura I., and Nakamura K. Carbon nanotubes with high bone-tissue compatibility and bone-formation acceleration effects. Small 4 (2008) 240-246
14. Chen X., Lee G., Zettl A., and Bertozzi C. Biomimetic engineering of carbon nanotubes by using cell surface mucin mimics. Angew Chem Int Ed 43 (2004) 6112-6116
15. Ciofani G., Obata Y., Sato I., Okamura Y., Raffa V., Menciassi A., et al. Realization, characterization and functionalization of lipidic wrapped carbon nanotubes. J Nanopart Res 11 (2009) 477-484
16. Park K.H., Chhowalla M., Iqbal Z., and Sesti F. Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem 278 50 (2003) 50212-50216
17. Bourlon B., Wong J., Mikó C., Forró L., and Bockrath M. A nanoscale probe for fluidic and ionic transport. Nature Nanotechnol 2 2 (2007) 104-107
18. Bianco A., and Prato M. Can carbon nanotubes be considered useful tools for biological applications?. Adv Mater 15 20 (2003) 1765-1768
19. Li S., He H., Jiao Q., and Chuong P.H. Applications of carbon nanotubes in drug and gene delivery. Prog Chem 20 (2008) 1798-1803
20. Inoue Y., Fujimoto H., Ogino T., and Iwata H. Site-specific gene transfer with high efficiency onto a carbon nanotube-loaded electrode. J Royal Soc Interf 5 (2008) 909-918
21. Liu Z., Winters M., Holodniy M., and Dai H. SiRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed 46 (2007) 2023-2027
22. Schipper M., Nakayama-Ratchford N., Davis C., Kam N., Chu P., Liu Z., et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nature Nanotechnol 3 (2008) 216-221
23. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 68 (2008) 6652-6660
24. Hilder T.A., and Hill J.M. Modelling the loading and unloading of drugs into nanotubes. Small 5 (2009) 300-308
25. Kam N.W.S., Liu Z., and Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 127 (2005) 12492-12493
26. Zhang Z., Yang X., Zhang Y., Zeng B., Wang S., Zhu T., et al. Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth. Clin Cancer Res 12 (2006) 4933-4939
27. Kostarelos K., Lacerda L., Pastorin G., Wu W., Wieckowski S., Luangsivilay J., et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nature Nanotechnol 2 (2007) 107-113
28. Hirano S., Kanno S., and Furuyama A. Multi-walled carbon nanotubes injure the plasma membrane of macrophages. Toxicol Appl Pharmacol 232 (2008) 244-251
29. Pan B., Cui D., Xu P., Ozkan C., Feng G., Ozkan M., et al. Synthesis, characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes, their application in gene delivery systems. Nanotechnology 20 (2009) 125101 [9pp.]
30. Arnold M., Guler M., Hersam M., and Stupp S. Encapsulation of carbon nanotubes by self-assembling peptide amphiphiles. Langmuir 21 (2005) 4705-4709
31. Witus L., Rocha J.D.R., Yuwono V.M., Paramonov S.E., Weismana R.B., and Hartgerink J.D. Peptides that non-covalently functionalize single-walled carbon nanotubes to give controlled solubility characteristics. J Mater Chem 17 (2007) 1909-1915
32. Dalton A., Ortiz-Acevedo A., Zorbas V., Brunner E., Sampson W.M., Collins S., et al. Hierarchical self-assembly of peptide-coated carbon nanotubes. Adv Funct Mater 14 (2004) 1147-1151
33. Pantarotto A., Partidos C., Graff R., Hoebeke J., Briand J., Prato M., et al. Synthesis, structural characterization, and immunological properties of carbon nanotubes functionalized with peptides. J Am Chem Soc 125 (2003) 6160-6164
34. Pantarotto A., Partidos C., Hoebeke J., Brown F., Kramer E., Briand J., et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol 10 (2003) 961-966
35. Nefzi A., Dooley C., Ostresh J.M., and Houghten R.A. Combinatorial chemistry: from peptides and peptidomimetics to small organic and heterocyclic compounds. Bioorg Med Chem Lett 8 (1998) 2273-2278
36. Annunziata P., Cioni C., Santonini R., and Paccagnini E. Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium. J Neuroimmun 131 (2002) 41-49
37. Gladysheva I.P., Moroz N.A., Karmakova T.A., Nemtsova E.R., Yakubovskaya R.I., and Larionova N.I. Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents. J Drug Target 9 (2001) 303-316
38. Marschutz M.K., and Bernkop-Schnurch A. Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro. Biomater 21 (2000) 1499-1507
39. Solakidi S., Dessypris A., Stathopoulos G.P., Androulakis G., and Sekeris C.E. Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and α1-antitrypsin in patients with gastrointestinal malignancies. Clin Biochem 37 (2004) 56-60
40. Aubin S., Martin B., Delcros J.G., Bonnemains Y.A., and Baudy-Floćh M. Retro hydrazino-azapeptoids as peptidomimetics of proteasome inhibitors. J Med Chem 48 (2005) 330-334
41. Huang H., Campbell S.C., Nelius T., Bedford D.F., Veliceasa D., Bouck N.P., et al. Α1-antitrypsin inhibits angiogenesis and tumor growth. Int J Cancer 112 (2004) 1042-1048
42. Yamamoto A., Taniguchi T., Rikyuu K., Tsuji T., Fujita T., Murakami M., et al. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res 11 (1994) 1496-1500
43. Morishita I., Morishita M., Takayama K., Machida Y., and Nagai T. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int J Pharm 78 (1992) 9-16
44. Beck A., Klinguer-Hamour C., Bussat M.C., Champion T., Haeuw J.F.O., Goetsch L., et al. Peptides as tools and drugs for immunotherapies. J Pept Sci 13 (2007) 588-602
45. Udugamasooriya D.G., Dineen S.P., Brekken R.A., and Kodadek T. A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity. J Am Chem Soc 130 (2008) 5744-5752
46. Gante J. Peptidomimetics - tailored enzyme inhibitors. Angew Chem Int Ed 33 (1994) 1699-1720
47. Sewald N., and Jakubke H.-D. Peptide and protein design, pseudopeptides, and peptidomimetics. Peptides: chemistry and biology (2002), Wiley-VCH Verlag GmbH & Co. KGaA 339-378
48. Cheguillaume A., Lehardy F., Bouget K., Baudy-Floćh M., and Le Grel P. Submonomer solution synthesis of hydrazinoazapeptoids, a new class of pseudopeptides. J Org Chem 64 (1999) 2924-2927
49. Bouget K., Aubin S., Delcros J.-G., Arlot-Bonnemains Y., and Baudy-Floćh M. Hydrazino-aza and N-azapeptoids with therapeutic potential as anticancer agents. Bioorg Med Chem 11 (2003) 4881-4889
50. Kaiser E., Colescott R.L., Bossinger C.D., and Cook P.I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 34 (1970) 595-598
51. Sarin V.K., Kent S.B., Tam J.P., and Merrifield R.B. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal Biochem 117 (1981) 147-157
52. 8]-substance P (6-11) in nude mice bearing the H69 small-cell lung cancer xenograft. Annals Oncol 6 (1995) 595-602 and references therein
53. 8]-Substance P(6-11) by a small cell lung cancer cell line (H69). Biochem Pharmacol 49 (1995) 1709-1712
54. Jones D.A., Cummings J., Langdom S.P., and Smyth J.F. Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist G. Gen Pharmacol 28 (1997) 183-189
55. Vakalopoulou P, Makrodouli H, Stavropoulos G, Voutsas J, Baxevanis C. In Flegel M, Fridkin M, Gilon C, Slaninova J, editor. Peptides 2004 (Proceedings of the 28th EPS). Prague, Czech Republic, Kennels; 2005. p. 968.
56. Thormann M., and Hofmann H.J. Conformational properties of azapeptides. J Mol Struct (Theochem) 469 (1999) 63-76
57. Kruijtzer J.A.W., Hofmeyer L.J.F., Heerma W., Versluis C., and Liskamp R.M.J. Solid-phase syntheses of peptoids using Fmoc-protected N-substituted glycines: the synthesis of (retro)peptoids of leu-enkephalin and substance P. Chem Eur J 4 (1998) 1570-1580
58. Bahr J.L., and Tour J.M. Highly functionalized carbon nanotubes using in situ generated diazonium compounds. Chem Mater 13 (2001) 3823-3824
59. Dyke C.A., and Tour J.M. Solvent-free functionalization of carbon nanotubes. J Am Chem Soc 125 (2003) 1156-1157
60. Dyke C.A., and Tour J.M. Unbundled and highly functionalized carbon nanotubes from aqueous reactions. Nano Lett 3 (2003) 1215-1218
61. Dyke C.A., Stewart M.P., Maya F., and Tour J.M. Diazonium-based functionalization of carbon nanotubes: XPS and GC-MS analysis and mechanistic implications. Synlett (2004) 155-160
62. Hudson J.L., Casavant M.J., and Tour J.M. Water-soluble, exfoliated, nonroping single-wall carbon nanotubes. J Am Chem Soc 126 (2004) 11158-11159
63. Stephenson J.J., Hudson J.L., Leonard A.D., Price B.K., and Tour J.M. Repetitive functionalization of water-soluble single-walled carbon nanotubes. Addition of acid-sensitive addends. Chem Mater 19 (2007) 3491-3498
64. Karousis N., Ali-Boucetta H., Kostarelos K., and Tagmatarchis N. Aryl-derivatized, water-soluble functionalized carbon nanotubes for biomedical applications. Mater Sci Eng B 152 (2008) 8-11
65. Sayes C.M., Liang F., Hudson J.L., Mendez J., Guo W., Beach J.M., et al. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 161 (2006) 135-142
66. Lacerda L., Bianco A., Prato M., and Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Deliv Rev 58 (2006) 1460-1470